Celcuity To Participate in Upcoming Investor Conferences
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, today announced that

Follow